Latest news
New research has found that molnupiravir offers modest longer term benefits to vaccinated adults. This is the latest outcome of the NIHR funded and delivered PANORAMIC trial, led by the University of Oxford.
- Published:
12 September 2024
Two new calls for research NIHR opens today are the next step in the UK’s commitment to stimulate brain tumour research in adults, children and young people.
- Published:
09 September 2024
The QbTest has been approved by NICE following successful trials by the NIHR
- Published:
05 September 2024
A new public-private investment programme will channel significant investment into the UK’s health and life sciences sector
- Published:
29 August 2024
Janusz Racz, 67, from London, is the first participant to receive the BioNTech vaccine at UCLH.
- Published:
23 August 2024
NIHR takes on management of Better Methods for Better Research (BMBR) programme
- Published:
21 August 2024
The NIHR has funded a new training programme to attract students and early career professionals into research..
- Published:
13 August 2024
A trial investigating whether ketamine-assisted therapy could help people with alcohol problems stop drinking is now recruiting participants.
- Published:
12 August 2024
The NIHR's new research volunteer registry Be Part of Research has reached 500,000 sign ups.
- Published:
08 August 2024
New NIHR paper recommends that primary care studies should be at the forefront of any future pandemic research
- Published:
08 August 2024
The new guiding principles provide stronger guidance for researchers in developing CEI plans.
- Published:
06 August 2024
Seven outstanding researchers join a prestigious group of leading health and care researchers as the latest cohort of NIHR Global Research Professors
- Published:
02 August 2024
New NIHR-funded research has found a link between problematic smartphone use and depression, anxiety, and insomnia in teens.
- Published:
02 August 2024
New data from the NIHR Clinical Research Network (CRN) shows an increase in GP practices taking part in research in 2023/24.
- Published:
01 August 2024
A new study funded by NIHR has found that public health measures that tackle dementia risk factors, could provide as much as £4 billion in savings in England.
- Published:
01 August 2024
A psoriasis drug can help treat children and adolescents with early-stage type-1 diabetes, an NIHR and MRC-funded study finds
Major study finds that the new shingles vaccine ‘Shingrix’ is more protective against dementia compared to the previous shingles vaccine.
A new study supported by NIHR has found that women treated for ovarian cancer caused by faulty BRCA genes have a lower risk of also developing breast cancer than previously thought.
Research funded by NIHR's School for Public Health Research has found that UK adolescents get around two-thirds of their daily calories from ultra-processed foods.
Dr Lisa Ledger has been appointed NIHR Assistant Director of Allied Health Professions.
An NIHR-funded study has found that over-the-counter nasal sprays are effective at reducing the symptoms and duration of flu and colds in at-risk patients. They could also reduce antibiotic use.
Leading scientists at NIHR have been recognised in the King’s Birthday Honours List for outstanding contributions to health and social care.
In partnership with Diabetes UK, NIHR is investing nearly £3 million into research to spot, treat and prevent type 1 diabetes distress.
12 NIHR professors have been recognised for exceptional contribution to biomedical and health research.
Researchers funded by the NIHR’s Oxford Biomedical Research Centre have created a standardised tool that will be rolled out nationally